CARA THERAPEUTICS INC (CARA)

US1407551092 - Common Stock

0.4226  +0.01 (+3.35%)

After market: 0.4089 -0.01 (-3.24%)

Buy % Consensus

49

ChartMill assigns a Buy % Consensus number of 49% to CARA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 1.03. This target is 143.78% above the current price.
CARA was analyzed by 9 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about CARA.
In the previous month the buy percentage consensus was at a similar level.
CARA was analyzed by 9 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 0.421.011.031.031.07 - 139.00% 143.78% 143.78% 153.43%
Up and Down Grades
Date Firm Action Rating
2024-06-13 Needham Downgrade Buy -> Hold
2024-06-13 Canaccord Genuity Downgrade Buy -> Hold
2024-06-13 HC Wainwright & Co. Downgrade Buy -> Neutral
2024-05-23 Needham Reiterate Buy -> Buy
2024-05-15 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-14 Needham Reiterate Buy -> Buy
2024-04-10 Needham Reiterate Buy -> Buy
2024-03-28 Needham Reiterate Buy -> Buy
2024-03-06 Canaccord Genuity Maintains Buy -> Buy
2024-03-05 Needham Reiterate Buy -> Buy
2024-01-22 Needham Maintains Buy -> Buy
2023-12-19 HC Wainwright & Co. Maintains Buy -> Buy
2023-12-18 Needham Maintains Buy -> Buy
2023-11-14 Piper Sandler Downgrade Overweight -> Neutral
2023-10-19 HC Wainwright & Co. Maintains Buy -> Buy
2023-08-08 Needham Reiterate Buy -> Buy
2023-08-08 Piper Sandler Maintains Overweight -> Overweight
2023-06-27 Stifel Reiterate Buy -> Buy
2023-06-27 Jefferies Reiterate Buy -> Buy
2023-05-16 Needham Reiterate Buy
2023-05-16 B of A Securities Maintains Underperform -> Underperform
2023-05-16 HC Wainwright & Co. Maintains Buy -> Buy
2023-04-18 Needham Reiterate Action List Buy
2023-04-04 Needham Reiterate Buy
2023-03-08 B of A Securities Downgrade Neutral -> Underperform
2023-03-07 Needham Maintains Buy
2023-03-07 JP Morgan Maintains Overweight
2023-03-07 Canaccord Genuity Maintains Buy
2023-03-07 Piper Sandler Maintains Overweight
2023-03-07 HC Wainwright & Co. Maintains Buy